...
首页> 外文期刊>Biomaterials >Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds
【24h】

Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds

机译:使用源自人iPS细胞和纳米纤维支架的功能性平滑肌细胞工程化血管组织

获取原文
获取原文并翻译 | 示例

摘要

Tissue-engineered blood vessels (TEBVs) are promising in the replacement of diseased vascular tissues. However, it remains a great challenge to obtain a sufficient number of functional smooth muscle cells (SMCs) in a clinical setting to construct patient-specific TEBVs. In addition, it is critical to develop a scaffold to accommodate these cells and retain their functional phenotype for the regeneration of TEBVs. In this study, human induced pluripotent stem cells (iPSCs) were established from primary human aortic fibroblasts, and characterized with the pluripotency markers expression and cells' capabilities to differentiate into all three germ layer cells. A highly efficient method was then developed to induce these human iPSCs into proliferative SMCs. After multiple times of expansion, the expanded SMCs retained the potential to be induced into the functional contractile phenotype of mature SMCs, which was characterized by the contractile response to carbachol treatment, up-regulation of specific collagen genes under transforming growth factor β1 treatment, and up-regulation of specific matrix metalloproteinase genes under cytokine stimulation. We also developed an advanced macroporous and nanofibrous (NF) poly(l-lactic acid) (PLLA) scaffold with suitable pore size and interpore connectivity to seed these human iPSC-derived SMCs and maintain their differentiated phenotype. Subcutaneous implantation of the SMC-scaffold construct in nude mice demonstrated vascular tissue formation, with robust collagenous matrix deposition inside the scaffold and the maintenance of differentiated SMC phenotype. Taken together, this study established an exciting approach towards the construction of patient-specific TEBVs. We established patient-specific human iPSCs, derived proliferative SMCs for expansion, turned on their mature contractile SMC phenotype, and developed an advanced scaffold for these cells to regenerate vascular tissue in vivo.
机译:组织工程血管(TEBV)在替换患病的血管组织方面很有前途。但是,在临床环境中获得足够数量的功能性平滑肌细胞(SMC)以构建患者特异性TEBV仍然是一个巨大的挑战。此外,开发支架以容纳这些细胞并保留其功能表型以再生TEBV至关重要。在这项研究中,从原代人主动脉成纤维细胞建立了人诱导的多能干细胞(iPSC),并以多能性标志物的表达和细胞分化为所有三个生殖层细胞的能力为特征。然后开发了一种高效的方法来诱导这些人iPSC进入增生SMC。经过多次扩增后,扩增的SMCs保留了被诱导为成熟SMCs的功能性收缩表型的潜力,其特征在于对卡巴胆碱处理的收缩反应,在转化生长因子β1处理下特定胶原基因的上调和细胞因子刺激下特定基质金属蛋白酶基因的上调。我们还开发了一种先进的大孔和纳米纤维(NF)聚(l-乳酸)(PLLA)支架,具有合适的孔径和孔间连接性,可以播种这些人iPSC衍生的SMC并保持其分化的表型。裸鼠中SMC支架构建物的皮下植入证明了血管组织形成,支架内部牢固的胶原基质沉积,并维持了分化的SMC表型。综上所述,这项研究建立了一种激动人心的方法来构建针对患者的TEBV。我们建立了患者特异性的人iPSC,衍生了增殖性SMC进行扩增,打开了它们成熟的收缩SMC表型,并为这些细胞开发了先进的支架,以在体内再生血管组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号